Cytokinetics raises ~$75M from underwriters' full exercise of overallotment option

CYTOKINETICS INC

Underwriters purchased 1,470,588 additional shares at $51.00 per share on June 7, 2024.
Gross proceeds of approximately $75 million before underwriting discounts and commissions.
Option exercised under May 22, 2024 underwriting agreement for initial offering of 9,803,922 shares.
Total shares sold in offering now 11,274,510; combined gross proceeds ~$575 million.
Net proceeds will be used for working capital and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.